BR9805921A - Enxertos feitos de membrana amniótica; processos de separação, conservação e uso desses enxertos em cirúrgias - Google Patents
Enxertos feitos de membrana amniótica; processos de separação, conservação e uso desses enxertos em cirúrgiasInfo
- Publication number
- BR9805921A BR9805921A BR9805921-1A BR9805921A BR9805921A BR 9805921 A BR9805921 A BR 9805921A BR 9805921 A BR9805921 A BR 9805921A BR 9805921 A BR9805921 A BR 9805921A
- Authority
- BR
- Brazil
- Prior art keywords
- grafts
- amniotic membrane
- membrane
- conservation
- surgery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Patente de Invenção: <B>"ENXERTOS FEITOS DE MEMBRANA AMNIóTICA; PROCESSOS DE SEPARAçãO, CONSERVAçãO E USO DESSES ENXERTOS EM CIRURGIAS"<D>. Processo para produção, armazenamento e uso de um enxerto cirúrgico de membrana amniótica humana; o enxerto e a solução de armazenamento. A membrana amniótica é obtida de placenta humana, da qual se separou o córion. As folhas da membrana amniótica são cortadas no tamanho e assentadas sobre papel de filtro. As células da membrana amniótica são exterminadas, de preferência, enquanto são congeladas e descongeladas na solução de armazenamento. A solução de armazenamento compreende um meio de cultura e um agente hiperosmótico, nos quais a hidratação da membrana é mantida. A membrana pode ser impregnada com agentes terapêuticos, antes do armazenamento, para uso em cicatrização pós-cirúrgica ou outras terapias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3948697P | 1997-02-28 | 1997-02-28 | |
PCT/US1998/003665 WO1998037903A1 (en) | 1997-02-28 | 1998-02-25 | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9805921A true BR9805921A (pt) | 2000-01-25 |
Family
ID=21905738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9805921-1A BR9805921A (pt) | 1997-02-28 | 1998-02-25 | Enxertos feitos de membrana amniótica; processos de separação, conservação e uso desses enxertos em cirúrgias |
Country Status (9)
Country | Link |
---|---|
US (2) | US6152142A (pt) |
EP (1) | EP0918529B1 (pt) |
JP (1) | JP2002515899A (pt) |
BR (1) | BR9805921A (pt) |
CA (1) | CA2252758C (pt) |
DE (1) | DE69839437D1 (pt) |
ES (1) | ES2307314T3 (pt) |
TW (1) | TW398982B (pt) |
WO (1) | WO1998037903A1 (pt) |
Families Citing this family (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000073421A2 (en) * | 1999-06-02 | 2000-12-07 | Lifebank Services, L.L.C. | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
AU2001253802B2 (en) * | 2000-04-27 | 2006-11-30 | Ray Jui-Fang Tsai | Method for expansion of epithelial stem cells |
CA2678490A1 (en) | 2000-12-06 | 2002-06-13 | Robert J. Hariri | Isolated placental perfusate and placental cells isolated therefrom |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
AU2002232437A1 (en) | 2000-12-20 | 2002-07-01 | Alcon Universal Ltd. | Ophthalmic lubricating solution adapted for use in lasik surgery |
AU2002230504A1 (en) | 2000-12-20 | 2002-07-01 | Alcon Universal Ltd. | Ophthalmic irrigating solution adapted for use in lasik surgery |
KR101132545B1 (ko) * | 2001-02-14 | 2012-04-02 | 안트로제네시스 코포레이션 | 산후 포유류의 태반, 이의 용도 및 태반 줄기세포 |
JP2004528021A (ja) * | 2001-02-14 | 2004-09-16 | アンスロジェネシス コーポレーション | 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞 |
US7347876B2 (en) * | 2001-04-25 | 2008-03-25 | Ray Jui-Fang Tsai | Method for expansion of epithelial stem cells |
JP3888573B2 (ja) * | 2001-06-29 | 2007-03-07 | 富士電機ホールディングス株式会社 | ハンダ組成物 |
EP1456354A4 (en) * | 2001-11-09 | 2005-11-09 | Artecel Sciences Inc | FROM FAT FIBERS GENERATING CURRENT CELLS FOR THE REPAIR OF HORNHAUT AND INTRAORBITAL DEFECTS AND USES THEREOF |
TWI290055B (en) * | 2002-03-14 | 2007-11-21 | Tissuetech Inc | Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes |
US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
EP1499710B1 (en) * | 2002-03-29 | 2011-08-24 | Singapore Eye Research Institute | Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
US20060147424A1 (en) * | 2002-08-23 | 2006-07-06 | Norio Sakuragawa | Human bone stem cells |
US20040057938A1 (en) * | 2002-09-18 | 2004-03-25 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
AU2003279132A1 (en) * | 2002-10-04 | 2004-05-04 | Tissuetech, Inc. | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
BR0316695A (pt) | 2002-11-26 | 2005-10-18 | Anthrogenesis Corp | Unidade citoterapêutica, kit para tratamento, método de tratamento de uma enfermidade, biblioteca de unidades citoterapêuticas e método de tratamento de um paciente |
US7727550B2 (en) * | 2003-02-21 | 2010-06-01 | The Uab Research Foundation | Biologically active native biomatrix composition |
US20050026279A1 (en) * | 2003-04-28 | 2005-02-03 | Tseng Scheffer C.G. | Surgical grafts and methods of preparation |
US20070010008A1 (en) * | 2005-06-29 | 2007-01-11 | Tissuetech, Inc. | Ex vivo expansion of primary animal cells |
WO2005021014A1 (fr) * | 2003-09-03 | 2005-03-10 | Jiuchang Miao | Preparation d'un amnios biologique conservable a temperature ambiante |
ES2404682T3 (es) | 2003-12-11 | 2013-05-28 | Isto Technologies Inc. | Sistema de cartílago particulado |
US20050186672A1 (en) * | 2004-01-27 | 2005-08-25 | Reliance Life Sciences Pvt. Ltd. | Tissue system with undifferentiated stem cells derived from corneal limbus |
US8187875B2 (en) * | 2004-02-26 | 2012-05-29 | Reliance Life Sciences Pvt. Ltd. | Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof |
US20060216821A1 (en) * | 2004-02-26 | 2006-09-28 | Reliance Life Sciences Pvt. Ltd. | Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof |
BRPI0509141A (pt) * | 2004-03-26 | 2007-09-04 | Celgene Corp | método para manter um registro de células-tronco, produto de programa de computação para uso junto com um sistema de computador, sistema de computador, e, meio legìvel por computador |
US20050287223A1 (en) * | 2004-06-23 | 2005-12-29 | Peyman Gholam A | Use of amniotic membrane as biocompatible devices |
RU2416638C2 (ru) | 2004-08-16 | 2011-04-20 | Селлрисерч Корпорейшн Пте Лтд. | Выделение стволовых клеток/клеток-предшественников из амниотической мембраны пуповины |
CN103356707B (zh) | 2005-03-31 | 2016-07-06 | 斯丹姆涅恩有限公司 | 制备用以治疗伤口或糖尿病性神经病引发的溃疡,或预防手术后疝形成的药物的方法 |
MX2007016268A (es) * | 2005-06-30 | 2009-02-23 | Anthrogenesis Corp | Reparacion de membrana timpanica utilizando biotela de colageno derivado de placenta. |
GB0514567D0 (en) * | 2005-07-15 | 2005-08-24 | Univ Nottingham | Surgical membrane |
EP1932549B1 (en) * | 2005-08-26 | 2016-12-28 | AMNOS Co., Ltd. | Dried amnion and method for drying treatment of amnion |
EP1916964A4 (en) | 2005-08-26 | 2015-11-04 | Zimmer Inc | IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES |
CA2623940C (en) | 2005-09-27 | 2017-01-10 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
US8187639B2 (en) | 2005-09-27 | 2012-05-29 | Tissue Tech, Inc. | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
PE20070771A1 (es) | 2005-10-13 | 2007-08-11 | Anthrogenesis Corp | Inmunomodulacion mediante el uso de celulas madres de la placenta |
FR2892311B1 (fr) * | 2005-10-24 | 2012-09-28 | Ets Francais Du Sang | Pansement pour la cicatrisation des plaies, ulceres ou brulures des epitheliums, endotheliums ou muqueuses. |
CN101389754A (zh) | 2005-12-29 | 2009-03-18 | 人类起源公司 | 胎盘干细胞和第二来源干细胞的联合培养 |
ES2708933T3 (es) | 2005-12-29 | 2019-04-12 | Celularity Inc | Poblaciones de células madre placentarias |
WO2007099556A2 (en) * | 2006-02-24 | 2007-09-07 | Reliance Life Sciences Pvt Ltd. | Conjunctival tissue system |
ES2918323T3 (es) | 2006-05-31 | 2022-07-15 | Childrens Medical Center | Células madre mesenquimatosas ABC5 positivas como inmunomoduladores |
AU2007258514A1 (en) * | 2006-06-09 | 2007-12-21 | Anthrogenesis Corporation | Placental niche and use thereof to culture stem cells |
US8105634B2 (en) * | 2006-08-15 | 2012-01-31 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
WO2008042441A1 (en) * | 2006-10-03 | 2008-04-10 | Anthrogenesis Corporation | Use of umbilical cord biomaterial for ocular surgery |
WO2008060377A2 (en) | 2006-10-04 | 2008-05-22 | Anthrogenesis Corporation | Placental or umbilical cord tissue compositions |
KR20160093739A (ko) | 2006-10-06 | 2016-08-08 | 안트로제네시스 코포레이션 | 천연(텔로펩티드) 태반 콜라겐 조성물 |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
ES2623141T3 (es) | 2007-01-17 | 2017-07-10 | Noveome Biotherapeutics, Inc. | Nuevos métodos para modular respuestas inflamatorias y/o inmunitarias |
EP2129775A1 (en) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
RS52921B (en) | 2007-02-12 | 2014-02-28 | Anthrogenesis Corporation | TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS |
US20080233552A1 (en) * | 2007-03-22 | 2008-09-25 | David Hui-Kang Ma | Method of cross-linking amnion to be an improved biomedical material |
US20090012629A1 (en) | 2007-04-12 | 2009-01-08 | Isto Technologies, Inc. | Compositions and methods for tissue repair |
AU2008239633B2 (en) | 2007-04-12 | 2014-05-29 | The Brigham And Women's Hospital, Inc. | Targeting ABCB5 for cancer therapy |
EP2164953A4 (en) | 2007-06-18 | 2010-06-30 | Childrens Hosp & Res Ct Oak | METHOD OF ISOLATING STAIN AND PRECIPITATING CELLS FROM PLAZENTA |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
EP3689421A1 (en) | 2007-09-07 | 2020-08-05 | MiMedx Group, Inc. | Placental tissue grafts and improved methods of preparing and using the same |
ES2530995T3 (es) | 2007-09-28 | 2015-03-09 | Anthrogenesis Corp | Supresión de tumor usando perfusato placentario humano y células asesinas naturales intermediarias que provienen de placenta humana |
WO2009044408A1 (en) * | 2007-10-03 | 2009-04-09 | International Centre For Cardio Thoracic And Vascular Diseases (A Unit Of Frontier Lifeline Pvt. Ltd) | A treated amniotic membrane and method of treating amniotic membrane |
US20090163990A1 (en) * | 2007-12-19 | 2009-06-25 | Chunlin Yang | Decellularized omentum matrix and uses thereof |
US8735054B1 (en) | 2008-01-04 | 2014-05-27 | Lifecell Corporation | Acellular tissue matrix preservation solution |
KR100947553B1 (ko) * | 2008-02-14 | 2010-03-12 | 주식회사 바이오랜드 | 생체조직 이식재 및 그의 제조 방법 |
US9358320B2 (en) | 2008-04-25 | 2016-06-07 | Allosource | Multi-layer tissue patches |
US9480549B2 (en) | 2008-04-25 | 2016-11-01 | Allosource | Multi-layer tissue patches |
US20110129520A1 (en) * | 2008-04-25 | 2011-06-02 | Simon Bogdansky | Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use |
US8709096B2 (en) | 2008-04-29 | 2014-04-29 | Proxy Biomedical Limited | Tissue repair implant |
EP2329012B1 (en) | 2008-08-20 | 2020-05-20 | Celularity, Inc. | Treatment of stroke using isolated placental cells |
NZ591292A (en) | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
CA2734446C (en) | 2008-08-22 | 2017-06-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
US7927414B2 (en) * | 2008-09-05 | 2011-04-19 | Ethicon, Inc. | Method of manufacturing acellular matrix glue |
US8858698B2 (en) * | 2008-09-05 | 2014-10-14 | Mentor Worldwide Llc | Acellular matrix glue |
US11542328B2 (en) | 2008-11-14 | 2023-01-03 | The Brigham And Women's Hospital, Inc. | Therapeutic and diagnostic methods relating to cancer stem cells |
EP3978928A1 (en) | 2008-11-14 | 2022-04-06 | The Brigham and Women's Hospital, Inc. | Therapeutic and diagnostic methods relating to cancer stem cells |
JP5869342B2 (ja) | 2008-11-19 | 2016-02-24 | アンスロジェネシス コーポレーション | 羊膜由来接着細胞 |
US8771677B2 (en) * | 2008-12-29 | 2014-07-08 | Vladimir B Serikov | Colony-forming unit cell of human chorion and method to obtain and use thereof |
US9150318B1 (en) | 2009-01-02 | 2015-10-06 | Lifecell Corporation | Method for sterilizing an acellular tissue matrix |
US9205177B2 (en) * | 2009-03-04 | 2015-12-08 | Peytant Solutions, Inc. | Stents modified with material comprising amnion tissue and corresponding processes |
CN101508971B (zh) * | 2009-03-23 | 2011-04-06 | 中国海洋大学 | 一种组织工程人角膜内皮的重建方法 |
DK2421901T3 (en) | 2009-04-24 | 2016-01-11 | Tissue Tech Inc | Compositions comprising HC-HA complex, and methods of use thereof |
NZ597436A (en) | 2009-07-02 | 2014-08-29 | Anthrogenesis Corp | Method of producing erythrocytes without feeder cells |
US8465471B2 (en) | 2009-08-05 | 2013-06-18 | Rocin Laboratories, Inc. | Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient |
US8348929B2 (en) | 2009-08-05 | 2013-01-08 | Rocin Laboratories, Inc. | Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient |
US20110213336A1 (en) | 2009-08-05 | 2011-09-01 | Cucin Robert L | Method of and apparatus for sampling, processing and collecting tissue and reinjecting the same into human patients |
EP2470231B1 (en) * | 2009-08-25 | 2019-10-09 | Tissue Tech, Inc. | Umbilical cord amniotic membrane products |
EP3284818B1 (en) | 2010-01-26 | 2022-03-09 | Celularity Inc. | Treatment of bone-related cancers using placental stem cells |
EP3345998A1 (en) | 2010-02-18 | 2018-07-11 | Osiris Therapeutics, Inc. | Immunocompatible chorionic membrane products |
TW202011974A (zh) | 2010-04-07 | 2020-04-01 | 美商安瑟吉納西斯公司 | 利用胎盤幹細胞之血管新生 |
TW201138792A (en) | 2010-04-08 | 2011-11-16 | Anthrogenesis Corp | Treatment of sarcoidosis using placental stem cells |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8840665B2 (en) | 2010-06-11 | 2014-09-23 | Liventa Bioscience, Inc. | Method of tendon repair with amnion and chorion constructs |
US20130156863A1 (en) * | 2010-06-30 | 2013-06-20 | Tissuetech, Inc. | Methods of preparing chorion tissue and products derived therefrom |
US20120010708A1 (en) * | 2010-07-08 | 2012-01-12 | AFcell Medical | Amnion and chorion replacement cover and uses thereof in surgical repair of muscles |
WO2012009422A1 (en) | 2010-07-13 | 2012-01-19 | Anthrogenesis Corporation | Methods of generating natural killer cells |
AR093183A1 (es) | 2010-12-31 | 2015-05-27 | Anthrogenesis Corp | Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras |
US9526770B2 (en) | 2011-04-28 | 2016-12-27 | Tissuetech, Inc. | Methods of modulating bone remodeling |
TWI602570B (zh) | 2011-06-01 | 2017-10-21 | 安瑟吉納西斯公司 | 使用胎盤幹細胞之疼痛治療 |
CA2837878A1 (en) | 2011-06-10 | 2012-12-13 | Tissuetech, Inc. | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof |
CN102908678A (zh) * | 2011-08-05 | 2013-02-06 | 高传友 | 一种治疗眼病的放置在泪道内的泪道棒 |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
US9585983B1 (en) * | 2011-10-12 | 2017-03-07 | BioDlogics, LLC | Wound covering and method of preparation |
US8932805B1 (en) | 2011-10-31 | 2015-01-13 | BioDlogics, LLC | Birth tissue material and method of preparation |
US9162011B2 (en) | 2011-12-19 | 2015-10-20 | Allosource | Flowable matrix compositions and methods |
US8961617B2 (en) | 2012-03-08 | 2015-02-24 | Liventa Bioscience, Inc. | Amnion and chorion constructs and uses thereof in abdominal surgery |
US9974645B2 (en) | 2012-08-07 | 2018-05-22 | RegenEye, L.L.C. | Method of reducing the occurrence of macular and neuroretinal degenerations by alleviating age related retinal stresses as a contributing factor in a mammalian eye |
US10265161B2 (en) | 2012-08-07 | 2019-04-23 | Regeneye L. L. C. | Ocular collar stent for treating narrowing of the irideocorneal angle |
US9308082B2 (en) | 2012-08-07 | 2016-04-12 | RegenEye, L.L.C. | Ocular collar stent for treating narrowing of the irideocorneal angle |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
US10905800B1 (en) | 2013-01-29 | 2021-02-02 | BioDlogics, LLC | Ocular covering and method of use |
EP2951289B1 (en) * | 2013-01-30 | 2019-10-02 | Nutech Medical, Inc. | Placental membrane preparation and methods of making and using same |
WO2014123879A1 (en) | 2013-02-05 | 2014-08-14 | Anthrogenesis Corporation | Natural killer cells from placenta |
AU2014219026B2 (en) | 2013-02-19 | 2018-11-29 | Children's Medical Center Corporation | ABCB5(+) stem cells for treating ocular disease |
US9498327B1 (en) | 2013-03-05 | 2016-11-22 | Biodlogics Llc | Repair of tympanic membrane using human birth tissue material |
US9789138B1 (en) | 2013-03-06 | 2017-10-17 | BioDlogics, LLC | Neural repair construct and method of use |
US11077229B1 (en) | 2013-03-08 | 2021-08-03 | BioDlogics, LLC | Implant coating composition and method of use |
US9770472B1 (en) * | 2013-03-08 | 2017-09-26 | Brahm Holdings, Llc | Organ jacket and methods of use |
AU2014248873B2 (en) | 2013-03-13 | 2017-03-23 | Allosource | Fascia fibrous compositions and methods for their use and manufacture |
US9855301B1 (en) | 2013-03-13 | 2018-01-02 | Biodlogics Llc | Human birth tissue laminate and methods of use |
US9511119B2 (en) | 2013-03-15 | 2016-12-06 | NuTech Spine, Inc. | Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same |
WO2014150784A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
US9795639B1 (en) | 2013-03-16 | 2017-10-24 | BioDlogics, LLC | Methods for the treatment of erectile dysfunction by human birth tissue material compostion |
US9993506B1 (en) | 2013-03-16 | 2018-06-12 | BioDlogics, Inc. | Methods for the treatment of degenerative disc diseases by human birth tissue material composition |
US9795638B1 (en) | 2013-03-16 | 2017-10-24 | BioDlogics, LLC | Cardiothoracic construct and methods of use |
US10039792B1 (en) | 2013-03-16 | 2018-08-07 | Brahm Holdings, Llc | Methods for the treatment of inflammation and pain using human birth tissue material composition |
US10555897B1 (en) | 2013-03-16 | 2020-02-11 | Brahm Holdings Llc | Cosmetic composition and methods of treatment |
WO2014182994A1 (en) | 2013-05-10 | 2014-11-13 | Children's Medical Center Corporation | Wound healing and tissue engineering |
US9795707B2 (en) | 2013-12-06 | 2017-10-24 | Allosource | Methods of drying sheets of donor-provided human birth tissue |
CA2948133A1 (en) * | 2014-05-07 | 2015-11-12 | Osiris Therapeutics, Inc. | Immunocompatible amniotic membrane products |
TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
MX2017000181A (es) | 2014-06-27 | 2017-05-01 | Univ California | Celulas madre limbales de mamifero cultivadas, metodos para generarlas y sus usos. |
CL2014002088A1 (es) * | 2014-08-06 | 2015-03-13 | Hernan Vasquez Zuloaga Dario | Procedimiento de envasado de membrana amniotica que mantiene su estructura para ser usada como injerto, que comprende adherir dicha membrana a un soporte, dimensionar la membrana junto con el soporte mediante un dispositivo de corte inerte, pegar la membrana junto con el soporte al interior de un contenedor y esterilizarla; membrana amniotica y su uso |
US10201573B1 (en) | 2014-10-27 | 2019-02-12 | Brahm Holdings, Llc | Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident |
US10265438B1 (en) | 2014-11-03 | 2019-04-23 | BioDlogics, LLC | Methods and compositions for the repair and replacement of connective tissue |
US10765705B2 (en) | 2014-11-24 | 2020-09-08 | Prime Merger Sub, Llc | Visco-supplement compositions, and methods of use thereof |
US20160243288A1 (en) | 2015-02-23 | 2016-08-25 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
CA2980316A1 (en) | 2015-03-24 | 2016-09-29 | Osiris Therapeutics, Inc. | Compositions comprising meniscal tissues and uses thereof |
CN104826166B (zh) * | 2015-05-06 | 2017-06-06 | 广州优适清生物科技有限公司 | 一种用于青光眼治疗的生物膜及其制备方法 |
CN104825493B (zh) * | 2015-05-06 | 2020-02-21 | 广州瑞泰生物科技有限公司 | 一种用于眼表治疗的生物羊膜及其制备方法 |
US10342831B2 (en) | 2015-05-20 | 2019-07-09 | Tissuetech, Inc. | Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
CA3177726A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
EP3386557B1 (en) * | 2015-12-11 | 2021-03-31 | LifeCell Corporation | Methods and systems for stiffening of tissue for improved processing |
KR20180095913A (ko) | 2015-12-23 | 2018-08-28 | 라이프넷 헬스 | 탈세포화된 태반막 및 이의 제조 방법 및 용도 |
TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
FR3047899A1 (fr) | 2016-02-18 | 2017-08-25 | Tbf - Genie Tissulaire Et Par Abreviation Tbf | Procede de preparation d'un materiau d'allogreffe, produit obtenu, et utilisations de celui-ci |
CN105561393A (zh) * | 2016-02-25 | 2016-05-11 | 岳邦超 | 一种羊膜巩膜镜支架 |
US10687934B2 (en) * | 2016-07-05 | 2020-06-23 | Carlos A. Alvarado | Serous membrane for ocular surface disorders |
WO2018039294A1 (en) | 2016-08-24 | 2018-03-01 | Arthrex, Inc. | Tissue use for repair of injury |
US10772986B2 (en) | 2017-01-26 | 2020-09-15 | Allosource | Fascia fibrous compositions and methods for their use and manufacture |
CN107296041B (zh) * | 2017-07-02 | 2020-12-25 | 江西瑞济生物工程技术股份有限公司 | 一种新鲜羊膜保存液及新鲜羊膜保存方法与应用 |
CN107952113A (zh) * | 2017-12-04 | 2018-04-24 | 遵义医学院 | 一种人羊膜神经管的制备方法及应用 |
US11285177B2 (en) | 2018-01-03 | 2022-03-29 | Globus Medical, Inc. | Allografts containing viable cells and methods thereof |
US20220008518A1 (en) * | 2018-11-08 | 2022-01-13 | The Schepens Eye Research Institute, Inc. | Therapeutic approaches for tissue reconstruction and wound healing treatment |
US11511017B2 (en) | 2019-03-12 | 2022-11-29 | Arthrex, Inc. | Ligament reconstruction |
CN110404119B (zh) * | 2019-08-29 | 2023-04-07 | 上海越增生物科技有限公司 | 羊膜组织工程去免疫原皮肤支架的制备方法 |
CN110975012B (zh) * | 2019-12-05 | 2021-11-16 | 博雅干细胞科技有限公司 | 去上皮细胞羊膜的制备方法 |
US11161204B1 (en) | 2020-04-10 | 2021-11-02 | Amnio Technology Llc | Allograft optimization system |
EP4240437A4 (en) * | 2020-11-05 | 2024-05-29 | MIMEDX Group Inc. | MESH PLACENTAL MEMBRANE TISSUE GRAFTS |
CN115105636B (zh) * | 2022-07-16 | 2024-03-19 | 沈阳汇智细胞产业技术创新研究院有限公司 | 脱细胞人羊膜的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL47062A (en) * | 1975-04-10 | 1979-07-25 | Yeda Res & Dev | Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde |
JPS5251009A (en) | 1975-10-17 | 1977-04-23 | Morinaga Milk Ind Co Ltd | Method of producing drug for treating marrow leukemia |
US4361552A (en) * | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
US4599226A (en) * | 1983-03-31 | 1986-07-08 | Genetic Laboratories, Inc. | Wound dressing comprising silver sulfadiazine incorporated in animal tissue and method of preparation |
US4599084A (en) | 1983-05-24 | 1986-07-08 | American Hospital Supply Corp. | Method of using biological tissue to promote even bone growth |
US4829000A (en) | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
DE3751254D1 (de) | 1986-10-31 | 1995-05-24 | Nippon Zeon Co | Wundverband. |
US5135915A (en) | 1988-10-14 | 1992-08-04 | Genentech, Inc. | Method for the treatment of grafts prior to transplantation using TGF-.beta. |
WO1991001720A1 (en) | 1989-08-07 | 1991-02-21 | Herman Wade Schlameus | Composition and method of promoting hard tissue healing |
CA2106955C (en) | 1991-03-26 | 2003-05-06 | Robert E. Burgeson | Product and method for improving keratinocyte adhesion to the dermis |
US5437287A (en) | 1992-08-17 | 1995-08-01 | Carbomedics, Inc. | Sterilization of tissue implants using iodine |
IL112580A0 (en) * | 1994-02-24 | 1995-05-26 | Res Dev Foundation | Amniotic membrane graft of wrap to prevent adhesions or bleeding of internal organs |
DE19511126A1 (de) * | 1995-03-19 | 1996-09-26 | Dizg Deutsches Inst Fuer Zell | Zellschichten und Transportsystem für Zellschichten |
DE29520965U1 (de) * | 1995-03-19 | 1996-10-02 | DIZG - Deutsches Institut für Zell- und Gewebeersatz gGmbH, 13125 Berlin | Zellschichten und Transportsystem für Zellschichten |
EP0735135A3 (de) * | 1995-03-31 | 1997-12-29 | DIZG Deutsches Institüt für Zell- und Gewebeersatz gGmbH | Zellschichten und Transportsystem für Zellschichten |
-
1998
- 1998-02-20 US US09/027,109 patent/US6152142A/en not_active Expired - Lifetime
- 1998-02-25 CA CA002252758A patent/CA2252758C/en not_active Expired - Lifetime
- 1998-02-25 ES ES98908712T patent/ES2307314T3/es not_active Expired - Lifetime
- 1998-02-25 BR BR9805921-1A patent/BR9805921A/pt not_active Application Discontinuation
- 1998-02-25 DE DE69839437T patent/DE69839437D1/de not_active Expired - Lifetime
- 1998-02-25 WO PCT/US1998/003665 patent/WO1998037903A1/en active Application Filing
- 1998-02-25 JP JP53780198A patent/JP2002515899A/ja not_active Ceased
- 1998-02-25 EP EP98908712A patent/EP0918529B1/en not_active Expired - Lifetime
- 1998-02-27 TW TW087102862A patent/TW398982B/zh not_active IP Right Cessation
-
2000
- 2000-07-25 US US09/625,481 patent/US6326019B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1998037903A1 (en) | 1998-09-03 |
EP0918529B1 (en) | 2008-05-07 |
EP0918529A4 (en) | 2003-02-05 |
US6152142A (en) | 2000-11-28 |
JP2002515899A (ja) | 2002-05-28 |
ES2307314T3 (es) | 2008-11-16 |
CA2252758A1 (en) | 1998-09-03 |
TW398982B (en) | 2000-07-21 |
DE69839437D1 (de) | 2008-06-19 |
US6326019B1 (en) | 2001-12-04 |
CA2252758C (en) | 2008-05-13 |
EP0918529A1 (en) | 1999-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9805921A (pt) | Enxertos feitos de membrana amniótica; processos de separação, conservação e uso desses enxertos em cirúrgias | |
Quinby Jr et al. | Clinical trials of amniotic membranes in burn wound care | |
ES2060750T3 (es) | Desarrollos clinicos que usan celulas amnioticas. | |
CL2010000606A1 (es) | Uso de derivados de eritropoyetina en la preparacion de un medicamento util para proteger, mantener, mejorar o recuperar la viabilidad de celulas que responden a eritropoyetina en condiciones anomalas que afectan las celulas, tejidos u organos asociados; derivados de eritropoyetinas y composicion que las comprende (divisional de la solicitud 3188-2001). | |
DK0532670T3 (da) | Kryokoservering af dyrkede epitelark | |
PT97832B (pt) | Processo para a preparacao de membranas biocompativeis perfuradas e de pele artificial | |
GB9400163D0 (en) | Membrane | |
AR036827A1 (es) | Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas | |
DK165169C (da) | Anvendelse af stoffer fra blodplader til fremstilling af topiske saarhelingsmidler | |
AU4500085A (en) | Electrolyte solutions containing polyanionic materials | |
Tsukita et al. | Electron microscope study of reassociation of spectrin and actin with the human erythrocyte membrane | |
BR9908631A (pt) | Glifosato como gameticida | |
BR9900299A (pt) | Corpos contendo polìmeros superabsorventes, processo para sua preparação e seu emprego | |
BRPI0415616A (pt) | uso do xenÈnio para a prevenção da morte programada da célula | |
Ingemansson et al. | Long-term preservation of vascular endothelium and smooth muscle | |
BR0002667A (pt) | Método de preparação de sais de complexo de lìtio para o uso em células eletroquìmicas | |
Dioguardi et al. | Skin substitutes in burn treatment-our experience | |
ES2085199B1 (es) | Un procedimiento para la preparacion de una formulacion depot. | |
Burke et al. | Primary excision and prompt grafting as routine therapy for the treatment of thermal burns in children | |
Wolf et al. | Evaluation of biological dressings | |
Ding et al. | Recent advances in burn wound management in China | |
DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
AU2001246812A1 (en) | Method and solutions for cryopreserving oocytes, especially fresh human oocytes | |
WO2001032154A3 (de) | Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation | |
Akanji et al. | Effect of repeated administration of suramin on alkaline phosphatase activity in rat kidney. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: TISSUETECH, INC. (US) Free format text: TRANSFERIDO DE: SCHEFFER C. G. TSENG |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |